Cardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes Acs

China Cardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes Acs, Find details about China Ticagrelor, Pharma Grade from Cardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes Acs

Model NO.
CAS NO. 274693-27-5
Appearance
White, Crystalline Powder
Transport Package
25kg/Drum
Origin
China
Model NO.
CAS NO. 274693-27-5
Appearance
White, Crystalline Powder
Transport Package
25kg/Drum
Origin
China
Cardiovascular APIs Ticagrelor CAS NO. 274693-27-5 for Acute Coronary Syndromes Acs 
 
Basic information:
Common NameTicagrelor
CAS Number274693-27-5Molecular Weight522.568
Density1.7±0.1 g/cm3Boiling Point777.6±70.0 °C at 760 mmHg
Molecular FormulaC23H28F2N6O4SMelting PointN/A
BRANDMONADFlash Point424.0±35.7 °C

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world's first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.

It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.


Erlotinib hydrochloride is a small molecule epidermal growth factor receptor tyrosine kinase reversible inhibitor, mainly used for second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and the treatment of pancreatic cancer

 

 

Pics:
Cardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes AcsCardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes AcsCardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes AcsCardiovascular Apis Ticagrelor CAS No. 274693-27-5 for Acute Coronary Syndromes Acs